In Adelaide's Flinders University, neuroscientists have reframed one of dementia's most feared culprits—discovering that tau protein, long cast as a villain in Alzheimer's disease, is actually essential for storing lasting memories in the brain. The finding, published in Nature Communications, reveals a paradox at the heart of memory loss: the very protein that malfunctions in dementia is the same one we need to remember our lives.
For decades, researchers have watched tau accumulate in the brains of dementia patients, where it tangles and destroys neural tissue. But Associate Professor Arne Ittner and his team at Flinders, working with collaborators from the University of New South Wales and Macquarie University, discovered that tau plays a quiet, essential role in how we transform fleeting moments into lasting memories. The work, titled "Tau T205 phosphorylation modulates engram cell recruitment and remote memory in mice," shows that without tau, memories can form in the immediate moment—but they remain fragile, fading like pencil sketches.
The study focused on "remote memory"—the kind of memory you access days or weeks after an experience. Researchers found that tau isn't needed for initial learning or short-term recall. Instead, it becomes critical when the brain decides which memories deserve to stick around. At the cellular level, this happens through specialized groups of brain cells called "engram cells," the physical substrate where memories live. During learning, only a small fraction of these cells are recruited to store a particular experience, and tau orchestrates this selection.
Renée Kosonen, one of the study's lead authors from Flinders' Neuroscience and Dementia Research team, describes tau's role as that of a precision organizer. "Tau helps determine which cells are selected to store a memory, shaping how an experience forms a lasting memory trace," she explains. Crucially, tau also filters out noise—preventing excess brain activity from cluttering the memory trace, which keeps memories clearer and more stable.
The researchers identified the molecular mechanism behind this process: during learning, tau undergoes a chemical modification called phosphorylation. While abnormal phosphorylation is a hallmark of Alzheimer's disease, the study reveals that controlled, low-level phosphorylation is actually a normal, healthy part of how brains cement memories. This distinction matters enormously. It suggests that targeting tau in dementia treatment is more nuanced than simply reducing it—the goal is restoring its healthy function.
The work also illuminates what happens when tau goes wrong. When disease-associated forms of tau were present during memory formation, they sabotaged the encoding process. When present later, they disrupted recall. Intriguingly, the researchers discovered that memory traces still existed even without tau—they simply couldn't be accessed through natural cues like sights or sounds. This suggests tau's role is specifically to link these sensory triggers to stored memories, not to store memories themselves.
"Knowing how tau supports the formation and recall of memory could help us better understand what goes wrong in memory loss," says Associate Professor Ittner. The findings open a new therapeutic direction: rather than viewing tau purely as a disease culprit, future treatments might aim to restore tau's normal function or protect it from the modifications that turn it toxic. As this research moves from mice to humans, it promises to rewrite our understanding of dementia—not as simple memory erasure, but as the disruption of the brain's careful machinery for organizing what we remember.